Australia's Control Bionics gains on UK and Ireland distribution agreement

Control Bionics

09/09/2024 03:24

** Shares of Australia's Control Bionics  CBL.AX  rise as
much as 3.5% to A$0.090; on track for second straight day of
gains, if trend holds
    ** Medical device maker signs exclusive distribution
agreement with UK-based Smart Box Ltd
    ** Adds agreement to expand sale of co's NeuroNode device
into the UK and Ireland
    ** NeuroNode used for individuals with conditions such as
Motor Neurone Disease, cerebral palsy, and other neurological
disorders that impair communication and motor function - CBL
    ** Stock up 95.7% YTD, as of 0220 GMT

 (Reporting by Roshan Thomas in Bengaluru)
 ((Roshan.Thomas@thomsonreuters.com))